Preclinical Imaging Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Preclinical Imaging Market by type of Product (Imaging Modalities, Single Photon emission computed tomography (SPECT), Micro Computed Tomography (Micro-CT), Magnetic Particle Imaging, Magnetic Resonance Imaging (MRI), Optical Imaging, X-Ray Imaging, Positron Emission Tomography (PET), Ultrasound , Reagents and Kits, Others), by Application (Research and Development, Drug Discovery), by End User (Biotech Companies, Pharmaceutical companies, Research institutes), and Geography

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Categories: Healthcare, Medical Devices

Description
Table Of Content
Company Profile

Report

Description

Preclinical Imaging Market size was valued at USD 870.4 million in 2021, growing at a CAGR of 7.1% during the forecast period 2022-2028. Preclinical imaging is used during drug discovery process in live animals. Preclinical imaging used for monitoring the treatment regime responses helpful for obtaining the early indications of efficacy. Technological improvements and advances in in-vivo clinical study providing the new opportunities to understand the clearly molecular level of details. Major preclinical imaging is targeted for diseases such as autoimmune diseases, cancers, cardiovascular diseases, and neurological disorders and others. Surge in adoption of sophisticated diagnostic technologies coupled with increased early diagnosis have expected to accelerate global preclinical imaging market. According to American Cancer Society, 14.1 million new cancer cases were diagnosed and 8.2 million cancer deaths in 2012. Companies adopting product innovations to increase their market share. Currently, the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET+CT and SPECT+CT are the most used imaging combinations. In-vivo imaging is increased usage in target identification, compound optimization and pre-Phase I study, and in the drug development process. Thus, it bridges the gap between in-vitro exploratory and in-vivo clinical research. Regions such as Latin America, Middle East, and Asia Pacific are witnessing an increase in foreign investments that is leading to greater revenue generation, for the market growth.

Key Developments:

In September 2016, Bruker Corporation signed an agreement to acquire the preclinical imaging business of Oncovision to increase their product portfolio

In March 2017, MR solutions introduced 9.4 tesla cryogen preclinical MRI imaging solution for cardiovascular sector

In February 2016, TriFoil Imaging installed InSyTe FLECT/CT Russia’s first 3D Optical imaging system at Novosibirsk

Preclinical Imaging Market

MARKET SUMMARY

7.1% CAGR

Study Period– 2022 – 2028
Base Year– 2021
CAGR– 7.1 %
Largest Market– North America
Fastest Growing Market– Europe

Preclinical Imaging Market

The report on global Preclinical Imaging Market gives historical, current, and future market sizes (US$ Mn) on the basis of type of product, application, end-use and region
Preclinical Imaging Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Key Players

MR Solutions (U.K.),
Siemens Ltd (U.S.),
Miltenyi Biotec (Germany),
Aspect Imaging (Canada),
MILabs B.V. (Netherlands),
Bruker Corporation (U.S.),

Drivers And Restraints

Preclinical Imaging Market

Rise in the number of contract research organizations (CRO), innovations in the devices used for small imaging technological advancements, and increase in number of drug trials due to rise in the incidence and prevalence of chronic diseases such as rheumatoid arthritis, cancer, cardiovascular & neurological disorders are some of the factors bolstering the preclinical imaging market growth. The huge cost of equipment, lack of skilled personnel to handle the equipment and lack of proper infrastructure are hindering the growth of the market. Furthermore, restrictions on animal drug testing by animal rights organizations are the major factors hampering growth of the market.

North-America got significant share

Preclinical Imaging Market

Geographically, global preclinical imaging market is segmented into Europe, North America, Latin America, Asia Pacific, and Middle East & Africa., North America expected to grow at significant rates due to increase in adoption of new technologies for better clinical outputs, technological advancements, and growing prevalence rates chronic diseases such as cardiovascular disease, cancer. According to the National Cancer Institute, in 2017, about 1,685,210 new cancer cases are expected to be diagnosed. Europe is expected to be another major market for preclinical imaging owing to factors such as increase in healthcare awareness among people and research and development activity for treating and preventing diseases. Asia-Pacific preclinical imaging market expected to show lucrative growth opportunity owing to cost-effective clinical and preclinical imaging services, coupled with favourable government policies.

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Key Features of the Report

The report provides granular level information about the market size, regional market share and forecast from 2021-2027
The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments and startup’s details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Segmentation

Preclinical Imaging Market

product type

Imaging Modalities
Single Photon emission computed tomography (SPECT)
Micro Computed Tomography (Micro-CT)
Magnetic Particle Imaging
Magnetic Resonance Imaging (MRI)
Optical Imaging
X-Ray Imaging
Positron Emission Tomography (PET)
Ultrasound
Others
Reagents and Kits

By Application

Research and Development
Drug Discovery

By End User

Biotech Companies
Pharmaceutical companies
Research institutes

Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Report

Table Of Content

1. Executive Summary

2. Global Preclinical Imaging Market Introduction

2.1. Global Preclinical Imaging Market – Taxonomy

2.2. Global Preclinical Imaging Market –Definitions

2.2.1. Product

2.2.2. Application

3. Global Preclinical Imaging Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Preclinical Imaging Market Dynamic Factors – Impact Analysis

3.6. Global Preclinical Imaging Market – Competition Landscape

4. Global Preclinical Imaging Market Analysis,2017-2021 and Forecast, 2022-2028

4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Preclinical Imaging Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.1. Medical Devices

5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. CT Imaging

5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. MRI Imaging

5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

5.4. PET/SPECT Imaging

5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.4.3. Market Opportunity Analysis

5.5. Multi-modal Imaging

5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.5.3. Market Opportunity Analysis

5.6. Optical Imaging

5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.6.3. Market Opportunity Analysis

5.7. Ultrasound Imaging

5.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.7.3. Market Opportunity Analysis

5.8. Photoacoustic (PAT) Imaging

5.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.8.3. Market Opportunity Analysis

5.9. Reagents

5.9.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.9.3. Market Opportunity Analysis

5.10. Services

5.10.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

5.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.10.3. Market Opportunity Analysis

6. Global Preclinical Imaging Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.1. Hospitals

6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Diagnostics Centers

6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Others

6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

7. Global Preclinical Imaging Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.1. North America

7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Europe

7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Asia-Pacific

7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Latin America

7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

7.5. Middle East and Africa

7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5.3. Market Opportunity Analysis

7.6. Global Preclinical Imaging Market – Opportunity Analysis Index, By Product, Application and Region, 2022-2028

8. North America Preclinical Imaging MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

8.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

8.1.1. Medical Devices

8.1.2. CT Imaging

8.1.3. MRI Imaging

8.1.4. PET/SPECT Imaging

8.1.5. Multi-modal Imaging

8.1.6. Optical Imaging

8.1.7. Ultrasound Imaging

8.1.8. Photoacoustic (PAT) Imaging

8.1.9. Reagents

8.1.10. Services

8.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

8.2.1. Hospitals

8.2.2. Diagnostics Centers

8.2.3. Others

8.3. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

8.3.1. USA

8.3.2. Canada

8.4. North America Preclinical Imaging Market – Opportunity Analysis Index, By Product, Application, and Country, 2022-2028

8.5. North America Preclinical Imaging Market Dynamics – Trends

9. Europe Preclinical Imaging Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

9.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

9.1.1. Medical Devices

9.1.2. CT Imaging

9.1.3. MRI Imaging

9.1.4. PET/SPECT Imaging

9.1.5. Multi-modal Imaging

9.1.6. Optical Imaging

9.1.7. Ultrasound Imaging

9.1.8. Photoacoustic (PAT) Imaging

9.1.9. Reagents

9.1.10. Services

9.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.2.1. Hospitals

9.2.2. Diagnostics Centers

9.2.3. Others

9.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.3.1. Germany

9.3.2. UK

9.3.3. France

9.3.4. Spain

9.3.5. Italy

9.3.6. Russia

9.3.7. Poland

9.3.8. Rest of Europe

9.4. Europe Preclinical Imaging Market – Opportunity Analysis Index, By Product, Application, and Country, 2022-2028

9.5. Europe Preclinical Imaging Market Dynamics – Trends

10. Asia-Pacific Preclinical Imaging Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

10.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

10.1.1. Medical Devices

10.1.2. CT Imaging

10.1.3. MRI Imaging

10.1.4. PET/SPECT Imaging

10.1.5. Multi-modal Imaging

10.1.6. Optical Imaging

10.1.7. Ultrasound Imaging

10.1.8. Photoacoustic (PAT) Imaging

10.1.9. Reagents

10.1.10. Services

10.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.2.1. Hospitals

10.2.2. Diagnostics Centers

10.2.3. Others

10.3. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.3.1. Japan

10.3.2. China

10.3.3. India

10.3.4. ASEAN

10.3.5. Australia & New Zealand

10.3.6. Rest of Asia-Pacific

10.4. Asia-Pacific Preclinical Imaging Market – Opportunity Analysis Index, By Product, Application, and Country, 2022-2028

10.5. Asia-Pacific Preclinical Imaging Market Dynamics – Trends

11. Latin America Preclinical Imaging Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

11.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

11.1.1. Medical Devices

11.1.2. CT Imaging

11.1.3. MRI Imaging

11.1.4. PET/SPECT Imaging

11.1.5. Multi-modal Imaging

11.1.6. Optical Imaging

11.1.7. Ultrasound Imaging

11.1.8. Photoacoustic (PAT) Imaging

11.1.9. Reagents

11.1.10. Services

11.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.2.1. Hospitals

11.2.2. Diagnostics Centers

11.2.3. Others

11.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.3.1. Brazil

11.3.2. Mexico

11.3.3. Argentina

11.3.4. Rest of Latin America

11.4. Latin America Preclinical Imaging Market – Opportunity Analysis Index, By Product, Application, and Country, 2022-2028

11.5. Latin America Preclinical Imaging Market Dynamics – Trends

12. Middle East and Africa Preclinical Imaging Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)

12.1. By Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

12.1.1. Medical Devices

12.1.2. CT Imaging

12.1.3. MRI Imaging

12.1.4. PET/SPECT Imaging

12.1.5. Multi-modal Imaging

12.1.6. Optical Imaging

12.1.7. Ultrasound Imaging

12.1.8. Photoacoustic (PAT) Imaging

12.1.9. Reagents

12.1.10. Services

12.2. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.2.1. Hospitals

12.2.2. Diagnostics Centers

12.2.3. Others

12.3. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.3.1. Gulf Cooperation Council (GCC) Countries

12.3.2. Israel

12.3.3. South Africa

12.3.4. Rest of MEA

12.4. MEA Preclinical Imaging Market – Opportunity Analysis Index, By Product, Application, and Country, 2022-2028

12.5. MEA Preclinical Imaging Market Dynamics – Trends

13. Competition Landscape

13.1. Strategic Dashboard of Top Market Players

13.2. Company Profiles (Introduction, Financial Analysis, Technology & Service Offerings, Key Developments, Strategies, and SWOT Analysis)

13.2.1. Bruker Corporation

13.2.2. Siemens A.G.

13.2.3. General Electric(GE)

13.2.4. Trifoil Imaging

13.2.5. PerkinElmer Inc.

13.2.6. Agilent Technologies

13.2.7. MILabs B.V

13.2.8. Fujifilm Holdings Corporation

13.2.9. MR Solutions Ltd

13.2.10. Li-Cor Biosciences

13.2.11. Mediso Ltd

13.2.12. Milabs BV

14. Research Methodology

15. Key Assumptions and Acronyms

Description

Description

Key Developments:

In September 2016, Bruker Corporation signed an agreement to acquire the preclinical imaging business of Oncovision to increase their product portfolio

In March 2017, MR solutions introduced 9.4 tesla cryogen preclinical MRI imaging solution for cardiovascular sector

In February 2016, TriFoil Imaging installed InSyTe FLECT/CT Russia’s first 3D Optical imaging system at Novosibirsk

search

Preclinical Imaging Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

Description

Preclinical Imaging Market

Preclinical Imaging Market

Preclinical Imaging Market

Preclinical Imaging Market

Key Features of the Report

Preclinical Imaging Market

product type

By Application

By End User

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE